跳至主要内容
临床试验/NCT04259554
NCT04259554已完成不适用

Orbitofrontal Cortex Transcranial Magnetic Stimulation in Patients With Emotionally Unstable Personality Disorder and Depression

University of Regensburg1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2020年2月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
1
主要终点
Hamilton depression rating scale (HDRS)

研究概览

简要总结

Treatment of depression with conventional transcranial magnetic stimulation (rTMS) has shown high evidence using high-frequency left dorsolateral prefrontal cortex (DLPFC) stimulation. Recently, it could be demonstrated that treatment of the right orbitofrontal cortex may be effective in patients who did not respond to conventional DLPFC rTMS. Orbitofrontal cortex (OFC) seem to be involved in the etiopathology of emotionally instable personality disorders. Thus, the present one-arm trial is a pilot study investigating if OFC rTMS is feasable, tolerable and effective.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ICD-10: F60.30 or F60.31
  • depressive symptoms and HAMD-21 score of at least 7
  • sex: female and male
  • residence in Germany and German speaking
  • written informed consent

排除标准

  • meeting the contraindications for transcranial magnetic stimulation (electric devices or metal implants in the body, e.g. cardiac pace maker, insulin pump)
  • neurological disorders (e.g. cerebrovascular events, neurodegenerative disorder, epilepsy, brain malformation, severe head trauma)
  • participation in another study parallel to the Trial
  • other mental or somatic illness which is not compatible with participation according to the principal investigator
  • pregnancy or breastfeeding period
  • psychiatric confinement

结局指标

主要结局

Hamilton depression rating scale (HDRS)

时间窗: 4 weeks

measurment of depressivity: 21 items with a range 0-65 and higher values indicating higher scores

次要结局

  • Depression module of the Patient health questionnaire (PHQ-D)(4 weeks, 12 weeks)
  • nicotine use(2 weeks, 4 weeks, 12 weeks)
  • Major Depression Inventory (MDI)(2 weeks, 4 weeks, 12 weeks)
  • Hamilton depression rating scale (HDRS)(2 weeks, 4 weeks, 12 weeks)
  • Borderline Symptom List (BSL-23)(2 weeks, 4 weeks, 12 weeks)
  • Clinical global impression (CGI)(2 weeks, 4 weeks, 12 weeks)
  • Barratt impulsiveness Scale (BIS)(4 weeks, 12 weeks)
  • Numeric rating scale of pain(2 weeks, 4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Berthold Langguth, MD, Ph.D.

Clinical Professor

University of Regensburg

研究点 (1)

Loading locations...

相似试验